OpenAlex
PricingAboutJobs
Log inGet started
Work

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder

HTML

Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Psychiatry
DOI: 10.4088/jcp.17m12058
Authors: Mary Hobart, Aleksandar Skuban, Peter Zhang, Carole Augustine, Claudette Brewer, Nanco Hefting, Raymond Sanchez, Robert D. McQuade
Institutions: Otsuka (United States), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States), Lundbeck (Denmark)
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: brexpiprazole, major depressive disorder, adjunctive therapy, antidepressant-refractory depression, atypical antipsychotics, treatment-resistant depression, anxious distress, functional disability, tolerability, fixed-dose dosing, Montgomery-Asberg Depression Rating Scale, Sheehan Disability Scale, outpatients, adults with depression, inadequate response to antidepressants
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2803445534
FWCI: 4.515
Cites:
Cited by: 77
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security